Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
ECTE (OTCBB: ECTE)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference
Nov 24, 2009 11:40 AM |
ECTE
NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Nov 20, 2009 03:02 PM |
CYCC
,
ECTE
,
EMIS
,
INO
,
PVCT
Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
Nov 19, 2009 08:01 AM |
ECTE
Echo Therapeutics Announces $3 Million Financing
Nov 13, 2009 08:05 AM |
ECTE
Emerging Stock Report Initiates Independent Research Coverage On Imaging3 Inc.
Nov 09, 2009 09:32 AM |
ECTE
,
IMGG
,
MDCI
Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
Nov 04, 2009 08:36 AM |
ECTE
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
Oct 29, 2009 08:13 AM |
ECTE
Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
Oct 01, 2009 08:08 AM |
ECTE
Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
Sep 09, 2009 02:31 PM |
ECTE
Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
Sep 08, 2009 12:27 PM |
ECTE
More..
More..
Echo Therapeutics to Present at Jessup & Lamont 2009 Growth Stock Conference
Jul 20, 2009 08:31 AM |
ECTE
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Jul 13, 2009 08:31 AM |
ACCP
,
CYTX
,
ECTE
,
JLI
,
NABI
Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference
Jul 09, 2009 09:02 AM |
ECTE
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
Jun 17, 2009 08:03 AM |
ECTE
Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine
May 28, 2009 08:01 AM |
ECTE
Echo Therapeutics to Present Clinical Study Results of Its Symphony Transdermal Continuous Glucose Monitoring System at Annual Diabetes Technology Meeting
Nov 13, 2008 08:02 AM |
ECTE
Echo Therapeutics to Present at Rodman & Renshaw's Annual Global Investment Conference
Nov 06, 2008 08:01 AM |
ECTE
Echo Therapeutics to Present at Rodman & Renshaw's Annual Global Investment Conference
Nov 06, 2008 08:01 AM |
ECTE
Echo Therapeutics Announces Issuance of New Patent for Symphony(TM) Transdermal Continuous Glucose Monitoring System
Oct 16, 2008 08:16 AM |
ECTE
Echo Therapeutics to Present at JMP Securities Healthcare Investor Conference - CNW
Oct 02, 2008 03:31 PM |
ECTE
More..
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ECTE
Compare to S&P
YTD
210.00 %
156.56 %
4 Weeks
-16.78 %
-17.68 %
12 Weeks
-22.50 %
-26.93 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-0.01 %
EPS Growth in Last Year:
78.57 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
